SDCBP Antikörper (AA 1-100)
-
- Target Alle SDCBP Antikörper anzeigen
- SDCBP (Syndecan Binding Protein (Syntenin) (SDCBP))
-
Bindungsspezifität
- AA 1-100
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SDCBP Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant SDCBP.
- Sequenz
- MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS LNEEEIRANV AVVSGAPLQG QLVARPSSIN YMVAPVTGND
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- SDCBP (NP_005616, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 2C12
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1." in: Experimental & molecular medicine, Vol. 46, pp. e90, (2014) (PubMed).
: "MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma." in: Cancer research, Vol. 73, Issue 2, pp. 844-54, (2013) (PubMed).
: "Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 17, pp. 4621-33, (2013) (PubMed).
: "Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma." in: Cancer research, Vol. 72, Issue 23, pp. 6217-26, (2012) (PubMed).
: "Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis." in: Molecular bioSystems, Vol. 7, Issue 6, pp. 1908-16, (2011) (PubMed).
: "
-
Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1." in: Experimental & molecular medicine, Vol. 46, pp. e90, (2014) (PubMed).
-
- Target
- SDCBP (Syndecan Binding Protein (Syntenin) (SDCBP))
- Andere Bezeichnung
- SDCBP (SDCBP Produkte)
- Synonyme
- MDA-9 antikoerper, ST1 antikoerper, SYCL antikoerper, TACIP18 antikoerper, Sycl antikoerper, syntenin-1 antikoerper, mda-9 antikoerper, st1 antikoerper, sycl antikoerper, tacip18 antikoerper, MGC81274 antikoerper, syntenin antikoerper, wu:fc51c03 antikoerper, wu:fk31e01 antikoerper, zgc:55679 antikoerper, zgc:77716 antikoerper, sb:eu862 antikoerper, si:dkey-235k4.1 antikoerper, syndecan binding protein antikoerper, syndecan binding protein L homeolog antikoerper, syndecan binding protein (syntenin) 2 antikoerper, syndecan binding protein (syntenin) antikoerper, SDCBP antikoerper, Sdcbp antikoerper, sdcbp.L antikoerper, LOC732879 antikoerper, sdcbp2 antikoerper, sdcbp antikoerper
- Hintergrund
-
Full Gene Name: syndecan binding protein (syntenin)
Synonyms: MDA-9,ST1,SYCL,TACIP18 - Gen-ID
- 6386
- NCBI Accession
- NM_005625
-